EQT II bought HemoCue in 1999 from Mallinckrodt Inc.
For more than 10 years, HemoCue had been a recognized global leader in professional diagnostics point-of-care testing. The product strategies behind HemoCue's success where based on a clear focus on important diagnostic tests of the highest quality, which was fast and easy to perform by anyone.
EQT II sold HemoCue in 2007 to Quest Diagnostics.
Key events during EQT's ownership
- New Management and “revitalized” vision and growth strategy
- Business realignment in Product Business Units with clear performance criteria and expectations
- Upgraded the Sales & Marketing organization globally and the distribution set-ups
- Increased R&D investments in the new product pipeline and expanded the existing technology platforms